Hand-foot syndrome is a biomarker of improved survival following treatment with capecitabine

Autor:	H. Jandu, Rachel Kerr, Claire Palles, Timothy Iveson, David N. Church, David J. Kerr, Ian Tomlinson, James Paul
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty business.industry Improved survival Hematology Hand-Foot Syndrome Capecitabine Palmar-plantar erythrodysesthesia syndrome Internal medicine Sickle cell dactylitis medicine Biomarker (medicine) business medicine.drug
Zdroj:	Annals of Oncology. 30:iv117-iv118
ISSN:	0923-7534
DOI:	10.1093/annonc/mdz156.024
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b0ffe2221f43d3ba6edcf7d7c0e3b34f https://doi.org/10.1093/annonc/mdz156.024 Zobrazit plný text záznamu